Rock Edwin's Form 4 filing
Crescent Biopharma, Inc. (CBIO) · filed Sep 25, 2023
- Accession no.
- 0001209191-23-050476
- Filed
- Sep 25, 2023
- Trade date
- Sep 21-22, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $90.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rock EdwinCIK 0001945417 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2023 | Common Stock | PPurchaseAcquired | +35,000 | $1.38 | +$48,300 | 345,000 | Direct | |
| Sep 22, 2023 | Common Stock | PPurchaseAcquired | +30,403 | $1.38 | +$41,956.14 | 375,403 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.